Marine Perriguey

Marseille, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Long-interval dosing of anti-CD20 therapy: Toward affordable treatment for multiple sclerosis.

Long-interval dosing of anti-CD20 therapy: Toward affordable treatment for multiple sclerosis.

Journal: Revue neurologique

Published: November 18, 2025

Prevalence of hypogammaglobulinemia after non-anti-CD20 therapies and impact of switching to rituximab/ocrelizumab in multiple sclerosis.

Prevalence of hypogammaglobulinemia after non-anti-CD20 therapies and impact of switching to rituximab/ocrelizumab in multiple sclerosis.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: June 19, 2025

Diagnostic Utility of Kappa Free Light Chain Index in Adults With Inaugural Optic Neuritis.

Diagnostic Utility of Kappa Free Light Chain Index in Adults With Inaugural Optic Neuritis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: March 14, 2025

Fluorescein Angiography as a Surrogate Marker of Disease Activity in Susac Syndrome.

Fluorescein Angiography as a Surrogate Marker of Disease Activity in Susac Syndrome.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: February 05, 2025

Extended-interval dosing of rituximab/ocrelizumab is associated with a reduced decrease in IgG levels in multiple sclerosis.

Extended-interval dosing of rituximab/ocrelizumab is associated with a reduced decrease in IgG levels in multiple sclerosis.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: October 15, 2024

Vestibular epilepsy: clinical and electroencephalographic characteristics with the proposed diagnostic criteria.

Vestibular epilepsy: clinical and electroencephalographic characteristics with the proposed diagnostic criteria.

Journal: Journal of neurology

Published: July 12, 2024

Effect of Prior Treatment With Fingolimod on Early and Late Response to Rituximab/Ocrelizumab in Patients With Multiple Sclerosis.

Effect of Prior Treatment With Fingolimod on Early and Late Response to Rituximab/Ocrelizumab in Patients With Multiple Sclerosis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: April 16, 2024

Efficacy of Rituximab Outlasts B-Cell Repopulation in Multiple Sclerosis: Time to Rethink Dosing?

Efficacy of Rituximab Outlasts B-Cell Repopulation in Multiple Sclerosis: Time to Rethink Dosing?

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: January 23, 2023

High-purified cannabidiol efficacy and safety in a cohort of adult patients with various types of drug-resistant epilepsies.

High-purified cannabidiol efficacy and safety in a cohort of adult patients with various types of drug-resistant epilepsies.

Journal: Revue neurologique

Published: January 08, 2023

Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With Rituximab.

Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With Rituximab.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: July 08, 2021

Ischemic stroke: A not so unusual complication of SMART syndrome?

Ischemic stroke: A not so unusual complication of SMART syndrome?

Journal: Revue neurologique

Published: July 07, 2020

Bilateral papillitis concomitant with cytomegalovirus primo-infection in an immunocompetent patient.

Bilateral papillitis concomitant with cytomegalovirus primo-infection in an immunocompetent patient.

Journal: Revue neurologique

Published: May 24, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026